The National Blood Authority (NBA) is pleased to announce that the Guideline for the prophylactic use of Rh D immunoglobulin in pregnancy care (the guideline) is now available.
The guideline was developed by a multidisciplinary expert reference group (ERG) using GRADE methodology and is a minor update of the 2021 guideline. The NBA gratefully acknowledges the dedication and clinical expertise provided by the ERG.
The guideline has recommendations and expert opinion points for health professionals on the appropriate use and timing of:
- pathology tests to identify maternal and fetal Rh D status
- prophylactic Rh D immunoglobulin in Rh D negative pregnant women
The guideline has been published on MAGICapp (an online guideline publishing platform) for more information and to access the guideline go to www.blood.gov.au/anti-d-0. A guideline summary, PDF version of the guideline, adaptable care pathway and technical reports are available within the guideline and on the webpage.
To assist with guideline implementation BloodSafe e-learning have developed an online education program RhD immunoglobulin for health professionals caring for Rh D negative pregnant women. It is available online at https://learn.bloodsafelearning.org.au/course/details/rhd-immunoglobulin.